Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Following closing of its transaction with Telix Pharmaceuticals, ImaginAb, Inc. will be focused on developing its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials ...
CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July ...
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will ...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
NDAQ:ASND) Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference ...
CPRI Investors Have Opportunity to Lead Capri Holdings Limited Securities Fraud Lawsuit
To join the Capri Holdings class action, go to https://rosenlegal.com/submit-form/?case_id=33109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the ...